Anti-UBE2M antibody

Cat.#: 100939

Special Price 145.0 USD

Availability: In Stock
- +

Add to cart to get an online quotation

Product Information

  • Product Name
    Anti-UBE2M antibody
  • Documents
  • Description
    Rabbit polyclonal to UBE2M
  • Tested applications
    WB, IP
  • Species reactivity
    Human UBE2M
  • Alternative names
    UBC12 antibody; UBC12 antibody; UBC-RS2 antibody; UBC12 antibody; hUbc12 antibody; UBC-RS2 antibody; UBC12 antibody; Ubc-rs2 antibody; 2510040H03Rik antibody; 2510040H03Rik antibody; hUbc12 antibody; Ubc-rs2 antibody
  • Isotype
    Rabbit IgG
  • Preparation
    Produced in rabbits immunized with a synthetic peptide corresponding to the center region of the Human UBE2M, and purified by antigen affinity chromatography.
  • Clonality
    Polyclonal
  • Formulation
    0.2 μm filtered solution in PBS
  • Storage instructions
    This antibody can be stored at 2℃-8℃ for one month without detectable loss of activity. Antibody products are stable for twelve months from date of receipt when stored at -20℃ to -80℃. Preservative-Free.
    Sodium azide is recommended to avoid contamination (final concentration 0.05%-0.1%). It is toxic to cells and should be disposed of properly. Avoid repeated freeze-thaw cycles.
  • Applications

    WB: 10-20 μg/ml

    IP: 1-4 uL/mg of lysate

  • Validations

    UBE2M Antibody, Rabbit PAb, Antigen Affinity Purified, Western blot

    UBE2M Antibody, Rabbit PAb, Antigen Affinity Purified, Western blot

    UBE2M Antibody, Rabbit PAb, Antigen Affinity Purified, Immunoprecipitation

    UBE2M Antibody, Rabbit PAb, Antigen Affinity Purified, Immunoprecipitation

  • Background
    UBE2M is a member of the ubiquitin-conjugating E2 family whose members perform the second step in the ubiquitination reaction. Initially identified as the main process for protein degradation, ubiquitination is believed nowadays to be crucial for a wider range of cellular processes. The outcome of the ubiquitin-conjugation reaction, and thereby the fate of the substrate, is heavily dependent on the number of ubiquitin molecules attached and how these ubiquitin molecules are inter-connected. To deal with this complexity and to allow adequate ubiquitination in time and space, a highly sophisticated conjugation machinery has been developed. In a sequential manner, ubiquitin becomes activated by an ubiquitin-activating enzyme (E1), which then transfers the ubiquitin to a group of ubiquitin-conjugating enzymes (E2s). Next, ubiquitin-loaded E2s are interacting with ubiquitin protein ligases (E3s) and ubiquitin is conjugated to substrates on recruitment by the E3. These three key enzymes are operating in a hierarchical system, wherein two E1s and 35 E2s have been found and hundreds of E3s have been identified in humans. 
  • References
    • Sjoerd J L van Wijk, et al. (2009) A comprehensive framework of E2-RING E3 interactions of the human ubiquitin-proteasome system. Mol Syst Biol. 5: 317.
    • Nandi D, et al. (2006) The ubiquitin-proteasome system. Journal of biosciences. 31 (1): 137-55.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"